Track topics on Twitter Track topics that are important to you
The post NICE recommends risankizumab to treat severe psoriasis appeared first on European Pharmaceutical Review.
Original Article: NICE recommends risankizumab to treat severe psoriasisNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...
Psoriasis is a common skin condition affecting 2-3% of the population of the United Kingdom, where the skins replacement process is sped taking 2-6 days instead of the usual 21 - 28 days for the replacement of skin cells. Patients experience an accumulat...